The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((4-(1-[11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)-quinoline ID: ALA1684440
PubChem CID: 51351520
Max Phase: Preclinical
Molecular Formula: C25H20N4O
Molecular Weight: 392.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: [11CH3]n1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1
Standard InChI: InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3/i1-1
Standard InChI Key: AZEXWHKOMMASPA-BJUDXGSMSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
1.7827 -14.4468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4879 -14.8721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4731 -15.6976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7509 -16.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0436 -15.6694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3214 -16.0660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3839 -15.6450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3690 -14.8194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3532 -14.4187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0605 -14.8475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2048 -14.4743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9166 -14.8886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6290 -14.4712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6316 -13.6456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3477 -13.2382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0613 -13.6524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0567 -14.4745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3405 -14.8859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0342 -12.8347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5202 -13.4808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7481 -13.1975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7800 -12.3717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5751 -12.1479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4060 -10.6777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1054 -11.1119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0775 -11.9360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3502 -12.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6508 -11.8874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6797 -11.0661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8562 -12.8688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
1 10 1 0
5 10 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
12 13 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
19 23 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
24 29 2 0
22 26 1 0
19 30 1 0
16 21 1 0
11 12 1 0
2 11 1 0
M ISO 1 30 11
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.46Molecular Weight (Monoisotopic): 392.1637AlogP: 5.28#Rotatable Bonds: 5Polar Surface Area: 52.83Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.31CX LogP: 4.67CX LogD: 4.67Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.41Np Likeness Score: -1.16
References 1. Tu Z, Fan J, Li S, Jones LA, Cui J, Padakanti PK, Xu J, Zeng D, Shoghi KI, Perlmutter JS, Mach RH.. (2011) Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain., 19 (5): [PMID:21315609 ] [10.1016/j.bmc.2011.01.032 ] 2. Sun J, Xiao Z, Haider A, Gebhard C, Xu H, Luo HB, Zhang HT, Josephson L, Wang L, Liang SH.. (2021) Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery., 64 (11.0): [PMID:34042442 ] [10.1021/acs.jmedchem.1c00115 ]